ZA727532B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA727532B
ZA727532B ZA727532A ZA727532A ZA727532B ZA 727532 B ZA727532 B ZA 727532B ZA 727532 A ZA727532 A ZA 727532A ZA 727532 A ZA727532 A ZA 727532A ZA 727532 B ZA727532 B ZA 727532B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA727532A
Other languages
English (en)
Inventor
L Lunts
A Oxford
S Garside
D Hartley
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of ZA727532B publication Critical patent/ZA727532B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA727532A 1971-11-19 1972-10-23 Heterocyclic compounds ZA727532B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (1)

Publication Number Publication Date
ZA727532B true ZA727532B (en) 1973-07-25

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA727532A ZA727532B (en) 1971-11-19 1972-10-23 Heterocyclic compounds

Country Status (18)

Country Link
US (1) US3840537A (bg)
JP (1) JPS563873B2 (bg)
AT (1) AT321923B (bg)
AU (1) AU472127B2 (bg)
BE (1) BE791025A (bg)
CA (1) CA990292A (bg)
CH (1) CH594671A5 (bg)
DE (1) DE2255172A1 (bg)
DK (1) DK138691B (bg)
ES (1) ES408736A1 (bg)
FR (1) FR2160407B1 (bg)
GB (1) GB1400999A (bg)
IE (1) IE37046B1 (bg)
IL (1) IL40686A (bg)
NL (1) NL7215646A (bg)
PH (1) PH9669A (bg)
SE (1) SE402915B (bg)
ZA (1) ZA727532B (bg)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
SK287161B6 (sk) 1997-11-12 2010-02-08 Bayer Healthcare Ag 2-Fenylsubstituované imidazotriazinóny, spôsob ich výroby, liečivá obsahujúce tieto látky a ich použitie
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
EP1107747A4 (en) 1998-08-26 2003-04-23 Smithkline Beecham Corp COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
DK1212089T3 (da) 1999-08-21 2006-07-24 Altana Pharma Ag Synergistisk kombination af Roflumilast og Salmeterol
MXPA03010119A (es) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas 2-fenilo sustituidas.
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE602004021363D1 (de) * 2003-04-01 2009-07-16 Smithkline Beecham Corp Imidazotriazin verbindungen zur behandlung von krebserkrankungen
EP2305682A1 (en) 2004-04-02 2011-04-06 OSI Pharmaceuticals, Inc. 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
SG166106A1 (en) * 2005-09-29 2010-11-29 Bayer Schering Pharma Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
MY148491A (en) * 2005-11-17 2013-04-30 Osi Pharm Inc FUSED BICYCLIC mTOR INHIBITORS
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
MX2011011025A (es) 2009-04-20 2011-11-02 Osi Pharmaceuticals Llc Preparacion de c-piracin-metilaminas.
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
TW201639851A (zh) * 2015-03-16 2016-11-16 大日本住友製藥股份有限公司 雙環咪唑衍生物
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-オキソ-1,2,4-トリアジン誘導体およびその医薬組成物

Also Published As

Publication number Publication date
GB1400999A (en) 1975-07-16
DE2255172A1 (de) 1973-05-24
FR2160407A1 (bg) 1973-06-29
AU4819172A (en) 1974-05-16
IE37046B1 (en) 1977-04-27
IL40686A0 (en) 1972-12-29
DK138691B (da) 1978-10-16
CA990292A (en) 1976-06-01
US3840537A (en) 1974-10-08
AT321923B (de) 1975-04-25
NL7215646A (bg) 1973-05-22
SE402915B (sv) 1978-07-24
JPS4857993A (bg) 1973-08-14
PH9669A (en) 1976-02-10
AU472127B2 (en) 1976-05-20
CH594671A5 (bg) 1978-01-13
BE791025A (fr) 1973-05-07
ES408736A1 (es) 1976-03-01
IL40686A (en) 1975-12-31
JPS563873B2 (bg) 1981-01-27
IE37046L (en) 1973-05-19
DK138691C (bg) 1979-03-26
FR2160407B1 (bg) 1975-10-17

Similar Documents

Publication Publication Date Title
ZA727532B (en) Heterocyclic compounds
CY971A (en) Cephalosporin compounds
AU7420774A (en) Heterocyclic compounds
ZA726667B (en) Heterocyclic compounds
CY980A (en) 3-substituted-morphinan derivatives
ZA722506B (en) Tetrachlorophthalide compounds
IL37749A0 (en) Heterocyclic compounds
MY7500263A (en) Heterocyclic compounds
HK22577A (en) Oxidiazolone derivatives
ZA718536B (en) Heterocyclic compounds
ZA715698B (en) Heterocyclic compounds
MY7800302A (en) Cephalosporin compounds
ZA72165B (en) Substituted m-trifluormethylphenylurea derivatives
ZA708344B (en) Heterocyclic compounds
ZA715697B (en) Heterocyclic compounds
GB1408201A (en) Adenosine-5-carboxylate derivatives
CY908A (en) Triazolyl-ethenyl-phenylene derivatives
AU468514B2 (en) Heterocyclic compounds
AU4775472A (en) New polyepoxide-polysiloxane compounds
ZA723919B (en) New heterocyclic compounds
ZA728675B (en) 3-oxyiminomethyl cephalosporin compounds
GB1402325A (en) Dibenzoxirenoazepine derivatives
CA863349A (en) Heterocyclic compounds
GB1401806A (en) Methylene-dioxyquinazoline derivatives
ZA725958B (en) Heterocyclic compounds